CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
OPERATING ACTIVITIES
Net income	$ 520.9	$ 871.2	$ 1,742.9	$ 2,574.8
Adjustments to reconcile net earnings to net cash provided from operating activities:
Depreciation, amortization and depletion	192.0	203.4	597.6	599.4
Equity earnings of affiliate, net of dividends received	0.1	2.8	(0.3)	(6.3)
Loss (gain) on foreign currency transaction effect	0.2	(36.6)	52.0	(50.0)
Provision (benefit) for deferred income taxes	52.6	(103.3)	84.5	(100.1)
Other, net	8.1	5.1	25.5	16.9
Change in operating assets and liabilities:
(Increase)/ decrease in accounts receivable	(1.2)	(57.7)	292.9	(424.5)
Decrease/ (increase) in inventories	30.9	(9.5)	(57.9)	(8.3)
(Decrease)/ increase in accounts payable and accrued liabilities	(24.9)	332.3	(768.6)	409.5
(Increase) / decrease in other operating assets and liabilities	(188.6)	12.9	(248.0)	53.3
Net cash provided by operating activities	590.1	1,220.6	1,720.6	3,064.7
INVESTING ACTIVITIES
Capital expenditures	(227.9)	(243.1)	(657.6)	(695.5)
Proceeds from (purchase) sale of short-term investments, net	242.3	(81.0)	486.6	(216.0)
Other		9.9		(0.6)
Net cash provided by (used in) investing activities	14.4	(314.2)	(171.0)	(912.1)
FINANCING ACTIVITIES
Cash dividends paid to common stockholders	(579.8)	(695.8)	(2,319.3)	(1,700.8)
Other, net	(0.3)	(1.6)	(4.0)	(4.3)
Net cash (used in) provided by financing activities	(580.1)	(697.4)	(2,323.3)	(1,705.1)
Effect of exchange rate changes on cash and cash equivalents	47.0	(19.6)	(43.8)	(47.4)
Increase in cash and cash equivalents	71.4	189.4	(817.5)	400.1
Cash and cash equivalents, at beginning of period	2,113.1	2,394.3	3,002.0	2,183.6
Cash and cash equivalents, at end of period	$ 2,184.5	$ 2,583.7	$ 2,184.5	$ 2,583.7